This year’s Iraty Award for Research in Retinal Diseases honors Leo A. Kim, MD, PhD, an Associate Professor of Ophthalmology at Harvard Medical School (HMS) and the Monte J. Wallace Ophthalmology...

Leo A. Kim, MD, PhD, a clinician scientist with surgical expertise and an innovator in the treatment of retinal diseases associated with neovascularization and fibrosis and an Associate Professor of...

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.

Boston, Mass.— A team led by...

Leo Kim, MD, PhD, received a grant from the E. Matilda Ziegler Foundation for the Blind, Inc. in the amount of $80,000 over three years for his project studying Runx1 in retinal neovascularization. He...

Faculty Recognition

Joseph Arboleda-Velasquez, MD, PhD, received a grant from the National Institute of Neurological Disorders and Stroke and National Institute of Aging/National Institutes of Health...

New findings may stimulate the development of targeted therapies for proptosis in patients with acute thyroid eye disease

Boston, Mass. —  Researchers from Mass. Eye and Ear - including Schepens Eye...

Faculty Awards

Joseph Arboleda-Velasquez, MD, PhD, and co-PI, Leo Kim, MD, PhD, received a Department of Defense grant in the amount of $1,499,592 over three years, for their project, "Testing...

On October 7^th and 8^th, Jason Comander, MD, PhD, and Leo Kim, MD, PhD, participated in the Alliance for Eye and Vision Research (AEVR) Emerging Vision Scientists Program. This program allows...